This test is not approved for New York state clients.
The patient's age and gender must be submitted, but the patient's height and weight are not required for NASH FibroSure® Plus testing.
For more information, please view the literature below.
Gel-barrier tube is preferred. Red-top tube is acceptable.
Separate serum from cells within two hours of collection.
Specimen can be stored refrigerated at 2°C to 8°C for 72 hours and frozen at -70°C for seven days. Frozen samples are stable for one freeze/thaw cycle.
Patient should be fasting for at least eight hours.
Gross hemolysis; gross lipemia; improper labeling; nonfasting specimen; patient younger than 14 years of age
This test is a noninvasive assessment of liver status in patients with nonalcoholic fatty liver disease (NAFLD). Quantitative results of 10 biochemicals in combination with age and gender are analyzed using a computational algorithm to provide a quantitative surrogate marker (0.0-1.0) of liver fibrosis (Metavir F0-F4), hepatic steatosis (0.0-1.0, S0-S3), and nonalcoholic steatohepatitis (NASH) (0.0-0.75, N0-N2). The absence of steatosis (S<0.41) precludes the diagnosis of NASH.
NASH FibroSure® Plus is recommended for patients with suspected nonalcoholic fatty liver disease. It is not recommended for patients with other liver diseases. It is also not recommended in patients with Gilbert disease, acute hemolysis, acute viral hepatitis, drug induced hepatitis, genetic liver disease, autoimmune hepatitis and/or extra- hepatic cholestasis. Any of these clinical situations may lead to inaccurate quantitative predictions of fibrosis.
This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.
See individual test components.
|Order Code||Order Code Name||Order Loinc||Result Code||Result Code Name||UofM||Result LOINC|
|550960||NASH FibroSure(R) Plus||93691-4||000000||2||48795-9|
|550960||NASH FibroSure(R) Plus||93691-4||000000||A||48794-2|
|550960||NASH FibroSure(R) Plus||93691-4||000000||2||93695-5|
|550960||NASH FibroSure(R) Plus||93691-4||000000||A||93696-3|
|550960||NASH FibroSure(R) Plus||93691-4||000000||2||93692-2|
|550960||NASH FibroSure(R) Plus||93691-4||000000||A||93693-0|
|550960||NASH FibroSure(R) Plus||93691-4||000000||1835-8|
|550960||NASH FibroSure(R) Plus||93691-4||000000||4542-7|
|550960||NASH FibroSure(R) Plus||93691-4||000000||1869-7|
|550960||NASH FibroSure(R) Plus||93691-4||000000||1||1975-2|
|550960||NASH FibroSure(R) Plus||93691-4||000000||2324-2|
|550960||NASH FibroSure(R) Plus||93691-4||000000||1743-4|
|550960||NASH FibroSure(R) Plus||93691-4||000000||30239-8|
|550960||NASH FibroSure(R) Plus||93691-4||000000||2093-3|
|550960||NASH FibroSure(R) Plus||93691-4||000000||2345-7|
|550960||NASH FibroSure(R) Plus||93691-4||000000||2571-8|
|550960||NASH FibroSure(R) Plus||93691-4||000000||S||93694-8|
|550960||NASH FibroSure(R) Plus||93691-4||000000||S||N/A|
|550960||NASH FibroSure(R) Plus||93691-4||000000||S||62364-5|
|550960||NASH FibroSure(R) Plus||93691-4||000000||A||8251-1|
|550960||NASH FibroSure(R) Plus||93691-4||000000||S||77202-0|
© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.
The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf